Effect of the HMG-CoA Reductase Inhibitor Rosuvastatin on Early Chronic Kidney Injury in Obese Zucker Rats Fed With an Atherogenic Diet

This publication has 42 references indexed in Scilit:

• Obesity Increases Blood Pressure, Cerebral Vascular Remodeling, and Severity of Stroke in the Zucker Rat
  Hypertension, 2009
• Progression of Kidney Disease in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin Versus Usual Care: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
  American Journal of Kidney Diseases, 2008
• Attenuation of NADPH Oxidase Activation and Glomerular Filtration Barrier Remodeling With Statin Treatment
  Hypertension, 2008
• Infection of Cardiomyocytes and Induction of Left Ventricle Dysfunction by Neurovirulent Polytropic Murine Retrovirus
  Journal of Virology, 2007
• HMG-CoA reductase inhibitors and the kidney
  Kidney International, 2007
• Rosuvastatin Treatment Prevents Progressive Kidney Inflammation and Fibrosis in Stroke-Prone Rats
  The American Journal of Pathology, 2007
• Substitution at Codon 269 (Glutamine → Proline) of the Leptin Receptor (OB-R) cDNA Is the Only Mutation Found in the Zucker Fatty (fa/fa) Rat
  Biochemical and Biophysical Research Communications, 1996
• Tubulointerstitial lesions in young zucker rats
  American Journal of Kidney Diseases, 1995
• Louis K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity.
  Hypertension, 1994
• Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation.
  Journal of Clinical Investigation, 1991